Triage of patients for short term observation after elective coronary angioplasty

Heart

Volumn 83, Issue 5, 2000, Pages 557-563

  Koch, K T ^a   Piek, J J ^a   Prins, M H ^a   De Winter, R J ^a   Mulder, K ^a   Lie, K I ^a   Tijssen, J G P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Angioplasty; Interventional cardiology; Triage

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0034122949     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.5.557     Document Type: Article

References (27)

1. Ellis SG, Miller DP, Brown KJ, et al. In-hospital costs of percutaneous coronary revascularisation. Circulation 1995;92:741-7.
2. Detre KM, Holmes DR, Holubkow R, et al, and the Co-investigators of the National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Incidence and consequences of periprocedural occlusion of the 1985-1986 National Heart, Lung and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990;82:739-50.
3. Steffino G, Meier B, Finci L, et al. Acute complications of elective coronary angioplasty: a review of 500 consecutive procedures. Br Heart J 1988;59:151-8.
4. De Feyter PJ, Van den Brand M, Laarman GJ, et al. Acute coronary artery occlusion during and after percutaneous, transluminal coronary angioplasty. Frequency, prediction, management and follow-up. Circulation 1991;83:927-36.
5. Ellis SG, Roubin GS, King SB, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988;77;372-9.
6. Ellis GE, Vandormael MG, Cowley MJ, et al, and the Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patients selection. Circulation 1990;82: 1193-202.
7. Savage MP, Goldberg S, Hirschfeld JW, et al. Clinical and angiographic determinants of primary coronary angioplasty success. J Am Coll Cardiol 1991;17:22-8.
8. Myler RK, Shaw RE, Stertzer SH, et al. Lesion morphology and coronary angioplasty; Current experience and analysis. J Am Coll Cardiol 1992;19:1641-52.
9. Lincoff AM, Popma JJ, Ellis SG, et al. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;19:926-35.
10. Tenaglia AN, Fortin DF, Califf RM, et al. Predicting the risk of abrupt vessel closure after angioplasty in an individual patient. J Am Coll Cardiol 1994;24:1004-11.
11. Tan K, Sulke N, Taub N, et al. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol 1995; 25:855-65.
12. Black AJR, Namay DL, Niederman AL, et al. Tear or dissection after coronary angioplasty: morphologic correlates of an ischemic complication. Circulation 1989;79:1035-42.
13. Huber MS, Mooney JF, Madison J, et al. Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 1991;68:467-71.
14. Agrawal SK, Ho DSW, Liu MW, et al. Predictors of thrombotic complications after placement of the flexible coil stent. Am J Cardiol 1994;73:1216-19.
15. Braunwald E. Unstable angina, a classification. Circulation 1989;80:4104.
16. Principal investigators of CASS and their associates. The National Heart, Blood and Lung Institute Coronary Artery Surgery Study. Circulation 1981;63:131-9.
17. TIMI Study Group. The Thrombolysis in Myocardial Infarction trial. N Eng J Med 1985;313:342-7.
18. Ryan TJ, Faxon DP, Gunnar RP, and ACC/AHA Task Force. Guidelines for percutaneous transluminal angioplasty. J Am Coll Cardiol 1988;12:529-45.
19. Dorros G, Cowley MJ, Simpson J, et al. Percutaneous transluminal coronary angioplasty: report of complications from The National Heart, Blood and Lung Institute PTCA registry. Circulation 1983;67:723-30.
20. Budde T, Haude M, Hopp HW, et al. A prognostic computer model to predict individual outcome in interventional cardiology; The Intervent Project. Eur Heart J 1997;18: 1611-19.
21. Topol EJ, Ellis SG, Fishman J, et al. Multicenter study of percutaneous transluminal coronary angioplasty for right coronary ostial lesions. J Am Coll Cardiol 1987;9: 1214-18.
22. Dimas AP, Grigera F, Arora RR, et al. Repeat coronary angioplasty as treatment for restenosis. J Am Coll Cardiol 1992;19:1310-14.
23. Lincoff AM, Cheng JE, Califf RM, et al, for the PROLOG investigators. Standard versus low dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularisation. Am J Cardiol 1997;79:286-91.
24. The Epilog Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularisation. N Eng J Med 1997;336: 1689-96.
25. Koch KT, Piek JJ, de Winter RJ, et al. Safety of low-dose heparin in elective coronary angioplasty. Heart 1997; 77:517-22.
26. Vainer J, Fleisch M, Gunnes P, et al. Low-dose heparin for routine coronary angioplasty and stenting. Am J Cardiol 1996;78:964-6.
27. Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269-75.